Villa G - Search Results

1

Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain.

Villa G, Hernández-Pastor LJ, Guix M, Lavernia J, Cuesta M. Villa G, et al. Clin Transl Oncol. 2015 Jan;17(1):24-33. doi: 10.1007/s12094-014-1191-9. Epub 2014 Jul 1. Clin Transl Oncol. 2015. PMID: 24981588

2

Budget impact analysis of first-line treatment with pazopanib for advanced renal cell carcinoma in Spain.

Villa G, Hernández-Pastor LJ. Villa G, et al. BMC Cancer. 2013 Sep 2;13:399. doi: 10.1186/1471-2407-13-399. BMC Cancer. 2013. PMID: 24004638 Free PMC article.

3

Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.

Villa G, Lothgren M, Kutikova L, Lindgren P, Gandra SR, Fonarow GC, Sorio F, Masana L, Bayes-Genis A, Hout BV. Villa G, et al. Clin Ther. 2017 Apr;39(4):771-786.e3. doi: 10.1016/j.clinthera.2017.02.011. Epub 2017 Mar 31. Clin Ther. 2017. PMID: 28366593

4

Cost-effectiveness analysis of timely dialysis referral after renal transplant failure in Spain.

Villa G, Sánchez-Álvarez E, Cuervo J, Fernández-Ortiz L, Rebollo P, Ortega F. Villa G, et al. BMC Health Serv Res. 2012 Aug 16;12:257. doi: 10.1186/1472-6963-12-257. BMC Health Serv Res. 2012. PMID: 22897891 Free PMC article.

5

Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States.

Gandra SR, Villa G, Fonarow GC, Lothgren M, Lindgren P, Somaratne R, van Hout B. Gandra SR, et al. Among authors: villa g. Clin Cardiol. 2016 Jun;39(6):313-20. doi: 10.1002/clc.22535. Epub 2016 Apr 19. Clin Cardiol. 2016. PMID: 27092712 Free PMC article.

6

Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease.

Fonarow GC, van Hout B, Villa G, Arellano J, Lindgren P. Fonarow GC, et al. Among authors: villa g. JAMA Cardiol. 2019 Jul 1;4(7):691-695. doi: 10.1001/jamacardio.2019.1647. JAMA Cardiol. 2019. PMID: 31166576 Free PMC article. Clinical Trial.

7

Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems.

Miravitlles M, Huerta A, Fernández-Villar JA, Alcázar B, Villa G, Forné C, Cuesta M, Crespo C, García-Río F. Miravitlles M, et al. Among authors: villa g. Health Qual Life Outcomes. 2014 Sep 5;12:120. doi: 10.1186/s12955-014-0120-5. Health Qual Life Outcomes. 2014. PMID: 25189786 Free PMC article.

8

Cost-effectiveness analysis of the Spanish renal replacement therapy program.

Villa G, Fernández-Ortiz L, Cuervo J, Rebollo P, Selgas R, González T, Arrieta J. Villa G, et al. Perit Dial Int. 2012 Mar-Apr;32(2):192-9. doi: 10.3747/pdi.2011.00037. Epub 2011 Sep 30. Perit Dial Int. 2012. PMID: 21965620 Free PMC article.

9

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.

Fonarow GC, Keech AC, Pedersen TR, Giugliano RP, Sever PS, Lindgren P, van Hout B, Villa G, Qian Y, Somaratne R, Sabatine MS. Fonarow GC, et al. Among authors: villa g. JAMA Cardiol. 2017 Oct 1;2(10):1069-1078. doi: 10.1001/jamacardio.2017.2762. JAMA Cardiol. 2017. PMID: 28832867 Free PMC article.

10

Cost analysis of the Spanish renal replacement therapy programme.

Villa G, Rodríguez-Carmona A, Fernández-Ortiz L, Cuervo J, Rebollo P, Otero A, Arrieta J. Villa G, et al. Nephrol Dial Transplant. 2011 Nov;26(11):3709-14. doi: 10.1093/ndt/gfr088. Epub 2011 Mar 21. Nephrol Dial Transplant. 2011. PMID: 21427072

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

873 results

Search Page

Filters